Strong compliance with gluten-free labeling could free FDA to focus more on cross contamination risk

Encouraged by positive early compliance rates with the ‘game-changing’ gluten-free labeling standard that went into effect in mid-2014, FDA could now focus its attention on reducing the risk of cross contact with gluten-containing foods and ingredients, according to the agency.